- Home
- NXC vs WGSWW Comparison
NXC vs WGSWW Comparison
Compare NXC & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXC
- WGSWW
- Stock Information
- Founded
- NXC 1992
- WGSWW 2017
- Country
- NXC United States
- WGSWW United States
- Employees
- NXC N/A
- WGSWW N/A
- Industry
- NXC Investment Managers
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- NXC Finance
- WGSWW Technology
- Exchange
- NXC Nasdaq
- WGSWW Nasdaq
- Market Cap
- NXC N/A
- WGSWW N/A
- IPO Year
- NXC N/A
- WGSWW N/A
- Fundamental
- Price
- NXC $13.19
- WGSWW $0.21
- Analyst Decision
- NXC
- WGSWW
- Analyst Count
- NXC 0
- WGSWW 0
- Target Price
- NXC N/A
- WGSWW N/A
- AVG Volume (30 Days)
- NXC 17.5K
- WGSWW 36.6K
- Earning Date
- NXC 01-01-0001
- WGSWW 02-18-2025
- Dividend Yield
- NXC 3.97%
- WGSWW N/A
- EPS Growth
- NXC N/A
- WGSWW N/A
- EPS
- NXC 0.19
- WGSWW N/A
- Revenue
- NXC N/A
- WGSWW $305,450,000.00
- Revenue This Year
- NXC N/A
- WGSWW N/A
- Revenue Next Year
- NXC N/A
- WGSWW N/A
- P/E Ratio
- NXC $70.47
- WGSWW N/A
- Revenue Growth
- NXC N/A
- WGSWW 50.79
- 52 Week Low
- NXC $11.86
- WGSWW $0.17
- 52 Week High
- NXC $13.70
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- NXC 53.49
- WGSWW N/A
- Support Level
- NXC $13.05
- WGSWW N/A
- Resistance Level
- NXC $13.27
- WGSWW N/A
- Average True Range (ATR)
- NXC 0.09
- WGSWW 0.00
- MACD
- NXC 0.01
- WGSWW 0.00
- Stochastic Oscillator
- NXC 65.23
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.